TrialNutrition journal2025

Impact of supplementing Limosilactobacillus fermentum MN-LF23 on the eradication of Helicobacter pylori with 14-day standard quadruple therapy: a randomized, double-blind, placebo-controlled trial.

Yuyang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.